Xilio anticipates nominating a development candidate for its PSMA program in the ATACR format in the third quarter of 2025 ...

Initiated APOLLO, a double-blind, placebo-controlled, confirmatory trial of bitopertin in adults and adolescents with EPP.

Q1 2025 Earnings Call Transcript May 8, 2025 Akebia Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.03, ...

The College Football Playoff is churning toward a 16-team format in the 2026 season, which raises significant logistical ...

Updated Phase 2 data to be presented at ASCO for vilastobart, a tumor-activated, Fc-enhanced, anti-CTLA-4, in combination with atezolizumab in patients with metastatic microsatellite stable colorectal ...

Out of work? This acronym helps you spot phony opportunities fast—and the principles apply to other types of fraud too.

MONTREAL, May 06, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (" Osisko Development " or the " Company ") reports its financial and operating results for the three months ...

Entera continued to generate intrinsic value with progress across our programs while significantly extending our cash runway into late 2026 via direct investment from marquis investors and our ...

Q1 2025 Earnings Call Transcript May 6, 2025 Genius Sports Limited beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.05. Operator: Thank you for standing by. My name is Cindy ...

Armanino Foods of Distinction boasts consistent sales growth, high operating margins, and solid FCF yield. See why I think ...

Hello everyone and welcome to Wallbox's first quarter 2025 earnings conference call and webcast. My name is Charlie and I'll be the operator for today's call. (Operator Instructions) I'd now like to ...